| 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) | |
|---|---|
| Identifiers | |
| Symbol | HMGCS1 |
| Alt. symbols | HMGCS |
| Entrez | 3157 |
| HUGO | 5007 |
| OMIM | 142940 |
| RefSeq | NM_002130 |
| UniProt | Q01581 |
| Other data | |
| EC number | 2.3.3.10 |
| Locus | Chr. 5 p14-p13 |
| 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) | |
|---|---|
| Identifiers | |
| Symbol | HMGCS2 |
| Entrez | 3158 |
| HUGO | 5008 |
| OMIM | 600234 |
| RefSeq | NM_005518 |
| UniProt | P54868 |
| Other data | |
| Locus | Chr. 1 p13-p12 |
| Hydroxymethylglutaryl-coenzyme A synthase N terminal | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
staphylococcus aureus 3-hydroxy-3-methylglutaryl-coa synthase
|
|||||||||
| Identifiers | |||||||||
| Symbol | HMG_CoA_synt_N | ||||||||
| Pfam | PF01154 | ||||||||
| Pfam clan | CL0046 | ||||||||
| InterPro | IPR013528 | ||||||||
| PROSITE | PDOC00942 | ||||||||
|
|||||||||
| Available protein structures: | |
|---|---|
| Pfam | structures |
| PDB | RCSB PDB; PDBe; PDBj |
| PDBsum | structure summary |
| Hydroxymethylglutaryl-coenzyme A synthase C terminal | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
staphylococcus aureus 3-hydroxy-3-methylglutaryl-coa synthase
|
|||||||||
| Identifiers | |||||||||
| Symbol | HMG_CoA_synt_C | ||||||||
| Pfam | PF08540 | ||||||||
| Pfam clan | CL0046 | ||||||||
| InterPro | IPR013746 | ||||||||
| PROSITE | PDOC00942 | ||||||||
|
|||||||||
| Available protein structures: | |
|---|---|
| Pfam | structures |
| PDB | RCSB PDB; PDBe; PDBj |
| PDBsum | structure summary |
In molecular biology, Hydroxymethylglutaryl-CoA synthase or HMG-CoA synthase EC 2.3.3.10 is an enzyme which catalyzes the reaction in which Acetyl-CoA condenses with acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). It is the second reaction in the mevalonate-dependent isoprenoid biosynthesis pathway. HMG-CoA is an intermediate in both cholesterol synthesis and ketogenesis. This reaction is over-activated in patients with diabetes mellitus type 1 if left untreated, due to prolonged insulin deficiency and the exhaustion of substrates for gluconeogenesis and the TCA cycle, notably oxaloacetate. This results in shunting of excess acetyl-CoA into the ketone synthesis pathway via HMG-CoA, leading to the development of diabetic ketoacidosis.
The 3 substrates of this enzyme are acetyl-CoA, H2O, and acetoacetyl-CoA, whereas its two products are (S)-3-hydroxy-3-methylglutaryl-CoA and CoA.
This enzyme belongs to the family of transferases, specifically those acyltransferases that convert acyl groups into alkyl groups on transfer.